Lisa Flashner

Chief Operating Officer @EITOxford | @EMILosAngeles

[EIT Oxford @EITOxford]

📢 We’re proud to share a new publication in @PLOS Global Public Health by a multidisciplinary team of experts across academia, industry, and leading public health agencies, including contributions from our senior leadership at EIT.

The paper introduces the Always On approach - a dual-purpose system for pathogen surveillance that integrates emergency detection with routine clinical care.

At a time when pandemic threats persist and antimicrobial resistance grows, this approach aims to sustain and enhance health security infrastructure while delivering actionable clinical diagnostics.

Congratulations to our incredible team and collaborators: Sir John Bell, Tamsin Berry, Ines Hassan, Romina Mariano Megan Akodu, Corinna Bull, Kumeren Govender.

Thank you for driving innovation at the intersection of health and technology! 🚀

You can read the full paper - A consensus statement on dual purpose pathogen surveillance systems: The always on approach – below.

https://t.co/r9XtWwjjCS

#GlobalHealth #Innovation #PathogenSurveillance #AlwaysOn

[EIT Oxford @EITOxford]

🎉 Last year EIT purchased the iconic and much loved Eagle and Child pub in the city centre of Oxford.

✍  For over 300 years, this venue has played host to some of Oxford's greatest minds, including C.S. Lewis and J.R.R. Tolkien, members of the Inklings writers group, who regularly met to discuss literature, philosophy and culture.

🏗️ With designs led by Norman Foster @FosterPartners , EIT plans to preserve, refurbish and reopen the Eagle and Child, maintaining its use as a treasured public house and continuing its legacy as a space for people to come together and collaborate.

📅 If you would like to find out more about our exciting plans, please come to our public consultation meeting at St John’s College, everyone is welcome!

Thursday 21st November
2pm – 7:30pm (drop in)
The Garden Quad
Reception Room
St John’s College
Oxford
OX1 3JP

[EIT Oxford @EITOxford]

We’re thrilled to announce that Dr. Emma Stanton, in partnership with Professor Gil McVean, will lead the EIT’s pioneering Pathogen Program - our first in a series of high-impact initiatives aimed at tackling some of the world’s most enduring problems.

🔬 The Pathogen Program will focus on creating end-to-end diagnostic solutions, tools for antimicrobial resistance (AMR) detection, and an “Always On” data and analytics platform. By advancing these capabilities, the program aims to prevent disease outbreaks from escalating into global pandemics.

You can meet Emma and the @EITPathogena team at the @TheUnion_TBLH conference from 12th -16th November, where she will be sharing how they aim to reshape global health through innovation and tenacity.

Read the full story to learn more about the Pathogen Program
https://t.co/kzL5OHNQTN

[EIT Oxford @EITOxford]

Not to be missed!

Join Sir John Bell, President of the Ellison Institute of Technology (EIT), and Oracle's Executive Chairman and CTO Larry Ellison for a Fireside Chat at the Oracle Health Summit on October 30th, 1:30 PM - 2:30 PM CDT.

With a digital pass, you can stream this event and access an inspiring line up of keynotes and mainstage sessions from anywhere.

Register today to be part of the conversation at the forefront of health innovation

🔗https://t.co/dwy3HG1GfR

#OracleHealthSummit24 #EIT #EITOxford #HealthTech #HealthInnovation @OracleHealth

[Ellison Medical Institute @EMILosAngeles]

Today is Metastatic Breast Cancer Awareness Day. 💗

Trish McDonnell, an oncology nurse at the @eitlosangeles Ellison Clinic who treats patients with breast cancer, sheds light on metastatic breast cancer, the most advanced stage of the disease.

While there is currently no cure for metastatic breast cancer, new research and treatments are giving patients more time and #HOPE, and dramatically reducing suffering. At EIT LA, we’re committed to advancing breakthroughs that bring us closer to transforming patient lives.

#MetastaticBreastCancer #BreastCancerAwarenessMonth

[Civitas Networks for Health @civitas4health]

Just in! A new article from @NEJM on the role of #HealthDataUtilities in Supporting #HealthAI, co-authored by Civitas’ @lisabari, @jlritzo, Ahmad Alkasir, Gabriel Seidman from Ellison Institute of Technology, and Anjum Khurshid from Harvard Medical School: https://t.co/yBeyNgdynY

[Shannon Mumenthaler @MumenthalerSM]

Join us on Sept. 26 for our @EITLosAngeles #InsightsForum, where expert oncologists & researchers will discuss if AI is living up to its potential in cancer research and care. What’s holding it back, & how can we fix it?

Register: https://t.co/kTv0Yxhq05

[Ellison Medical Institute @EMILosAngeles]

@EITLosAngeles Chief Strategy Officer Dr. @annabarker20 and EIT Visiting Member @cliftonleaf joined the @PressClubDC press conference to highlight the groundbreaking progress achieved by the @QuantumLeapHC I-SPY 2.2 clinical trials. This new generation of patient-centered trials is poised to not only improve the health outcomes of early stage high-risk breast cancer patients, but to also accelerate the development of targeted treatments and therapies for other cancers and complex diseases.

We are excited for efforts like this to drive advancements in precision oncology for patient benefit 🙌

[EIT Oxford @EITOxford]

Time is ticking! 📷 Less than two weeks remain to apply for the graduate Ellison Scholars Programme - deadline is September 30th!

Don’t wait - get started on your application today - https://t.co/20igWG4caj

Scholars receive a full scholarship to the @UniofOxford while contributing to groundbreaking innovation projects at EIT Oxford. These projects are dedicated to using cutting-edge technology to tackle the world’s biggest challenges.

Curious to learn more? Our team have put together a video with everything you need to know about the programme.

Watch it now! 📷https://t.co/Ch8whuSp5x

@EllisonInst @EITLosAngeles #Scholarship #AcademicScholarship #InnovationProjects #Oxford

[Ellison Medical Institute @EMILosAngeles]

Last year, our @EITLosAngeles #InsightsForum brought together a panel of experts to explore AI’s potential to revolutionize cancer treatment, diagnosis, and prevention.

Join us for our Sept. Insights Forum as we revisit AI's role in cancer care one year later. Why isn't it delivering better patient diagnostics, treatments, and preventatives as expected? What’s holding it back, and how can we fix it?

RSVP now: https://t.co/30mZMjFwu8

[EIT Oxford @EITOxford]

Exciting times ahead with the launch of @EITPathogena! This cutting-edge technology platform is set to revolutionise pathogen sequencing analysis, empowering labs to work faster and smarter. Proud to collaborate with the brilliant minds at @University of Oxford and @Oracle on this innovation.

Looking forward to seeing how EIT Pathogena helps healthcare and public health professionals worldwide to streamline their work and make a real impact in the fight against infectious diseases!

See more on the benefits of EIT Pathogena below.

#PathogenGenomics #EITPathogena #HealthTech #EITOxford

[EIT Oxford @EITOxford]

🚨 Global Health Update at EIT Oxford!

We’re pleased to announce that today marks the official launch of @EITPathogena, our first genomic analysis tool developed by the Pathogen Programme, one of the first health and medical science initiatives at EIT Oxford!

With a mission to reduce lives lost to infectious diseases and to prevent local outbreaks from becoming pandemics, EIT Pathogena is a global, free tool for public health professionals. By leveraging the cutting-edge, cloud-based technology of @Oracle, EIT Pathogena empowers users to process, analyse, and share genomic sequence data to combat infectious diseases.

Explore more at https://t.co/I9uHLGFoyx 🌍

#PathogenProgramme #EITPathogena #EITOxford #GenomicInnovation #InfectiousDiseases #Genomics #HealthTech

[EIT Oxford @EITOxford]

Special recognition post! 📢

Last week, the world’s first lung cancer vaccine trials launched in seven countries, with the first UK patient being treated. This was a cumulation of a strategy to empower scientists and trialists, enabled by @drlennardlee, which confirms the UK as the best place for cancer vaccine research.

His efforts include:

➡ Empowering the clinical community with emerging technological opportunities, ensuring the most efficient process to patient benefit.
➡ Designing and facilitating the NHS Cancer Vaccine Launchpad, a national system designed to streamline patient enrolment in cancer vaccine trials.
➡ This builds on lessons from previous successful programmes such as the NHS-Galleri trial, the lateral flow moonshot, and the UK COVID cancer programme.

The UK research community is now on course to place 10,000 people through trials by 2030, make significant scientific gains across all subtypes of cancer, and stimulate a global technological advance.

We are delighted to share that @drlennardlee an outstanding academic clinician (@UniofOxford) will be working on our Oxford University-EIT alliance. Lennard will lead our new EIT Oxford Clinic (opening in 2027) and establish it as a centre for innovation and healthcare excellence, setting a new standard for clinical care and research integration. It will deliver compassionate, technology-driven clinical care to cancer and preventive medicine patients.

Congratulations Lennard - let’s dare to dream big how healthcare and technologies can be re-imagined!

@DavidAgus @EITLosAngeles @EllisonInst